
Cizzle Biotechnology shareholder approval for Conduit-Murphy merger and NASDAQ listing
Cizzle Biotechnology Holdings plc (LON:CIZ), the UK based diagnostics developer, has announced a further update regarding the Company’s put option to sell its 5% economic interest and royalty sharing agreement in